Sentences with phrase «accelerated vaccine development»

As a member of the Vaccine & Immunotherapy Center he studied accelerated vaccine development and targeted cancer therapies until February 2015.

TRANSVAC will further accelerate vaccine development by developing and applying cutting - edge technologies to address critical issues in modern vaccine development and thereby increase the quality of services provided.

As such, in order to accelerate vaccine development, TRANSVAC undertakes significant effort to develop and validate new assays.

The testing could accelerate vaccine development but requires infecting chimps with potentially horrible diseases.

Not exact matches

In September 2007, Aeras received a $ 200 million grant from the Bill & Melinda Gates Foundation to accelerate TB vaccine development.

This can inform and accelerate the development of new vaccines, especially important during outbreaks and epidemics when clinical testing of vaccine candidates need to be fast tracked.

This result can inform and accelerate rational development of other new vaccines based on living viruses.

For the near term, groups known as accelerated development and introduction plans (ADIPs) have studied the possibility of more rapidly introducing new vaccines for rotavirus, a common diarrheal disease, and pneumococcus, a bacterium that causes pneumonia.

«In addition, our method offers the potential to accelerate the development of new vaccines by allowing the efficient evaluation of candidate target antigens.»

Academic and non-academic research groups, including SMEs, can apply to benefit from the expertise, reagents, and facilities offered by TRANSVAC2 to accelerate the development of their vaccines.

In order to facilitate access to these skills and capacities, and to promote collaborations in the European vaccine landscape - aiming thereby to accelerate the development of safe, effective and affordable vaccines - the EC, in the context of the Horizon 2020 Framework Programme, has recently funded «TRANSVAC2», a European vaccine research and development (R&D) infrastructure.

TRANSVAC is an infrastructure project that aims to accelerate the development of effective vaccines...

These centers focus the efforts of collaborative groups of researchers on defined areas of inquiry, to accelerate progress toward the development of new treatments and vaccines to prevent and cure type 1 diabetes, cancer and infectious disease.

In 2016, Moderna received a funding award of up to $ 125 million from the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), to accelerate development of its Zika mRDevelopment Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), to accelerate development of its Zika mRdevelopment of its Zika mRNA vaccine.

If validated, the model will accelerate placental malaria vaccine development by facilitating quicker down - selection of vaccine candidates and providing safety data in pregnant primates at pre-clinical stage.

TBVI will continue to support global efforts to accelerate TB vaccine discovery and development through increasing innovation, collaboration and coordination.

Through this, we will accelerate the development of vaccines against bacterial infections, particularly those relevant to LMICs.

Army signs Cooperative Research and Development Agreement to accelerate progress toward effective vaccine

For example, the UK government's program for tackling HIV and AIDS in the developing world, which was published shortly after the Bangkok meeting, makes the unqualified comment that the enterprise «will accelerate research and development of an effective vaccine.»

By bringing together for the first time three of Europe's leading vaccine development and manufacture companies as well as top experts from academic institutions and small and medium - sized enterprises (SMEs), the project will ultimately accelerate the development and introduction of a new generation of safer, more effective vaccines.

The Human Vaccines Project is a new public - private partnership, with the goal of accelerating development of improved vaccines and immunotherapies for global infectious diseases and cancers by decoding the human immuneVaccines Project is a new public - private partnership, with the goal of accelerating development of improved vaccines and immunotherapies for global infectious diseases and cancers by decoding the human immunevaccines and immunotherapies for global infectious diseases and cancers by decoding the human immune system.

Global HIV Vaccine Enterprise An alliance of independent organizations dedicated to accelerating the development of a preventive HIV vVaccine Enterprise An alliance of independent organizations dedicated to accelerating the development of a preventive HIV vaccinevaccine.

Dr Odile Leroy, Executive Director of the European Vaccine Initiative (EVI) and coordinator of TRANSVAC2, said: «The TRANSVAC2 activities will further strengthen the vaccine R&D infrastructure in Europe and will thereby accelerate the development of effective vaccines that are urgently needed to address global health challenges&Vaccine Initiative (EVI) and coordinator of TRANSVAC2, said: «The TRANSVAC2 activities will further strengthen the vaccine R&D infrastructure in Europe and will thereby accelerate the development of effective vaccines that are urgently needed to address global health challenges&vaccine R&D infrastructure in Europe and will thereby accelerate the development of effective vaccines that are urgently needed to address global health challenges».

TRANSVAC is a new infrastructure project - funded by the European Commission in the context of Horizon 2020 - that aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal to build an efficient and sustainable collaboration of experts and facilities to catalyse vaccine research in Europe.

Before joining EDCTP, Prof. Mgone was the Network Director of the African Malaria Network Trust (AMANET) responsible for coordinating capacity development and networking in accelerating the development and assessment of malaria vaccines and other interventions.

In: The Jordan Report 2000: Accelerated Development of Vaccines, NIAID, U.S. Division of Microbiology and Infectious Diseases, Bethesda, MD, p. 91 - 93.